Skip to main content

Ayuvant

The startup provides cancer immunotherapy services utilizing RNA nanoparticles that instruct the immune system to identify and target cancer cells. This approach enhances the effectiveness of RNA medicines, improving patient immunization and recovery times.

Traction 7/10
Utrecht, Netherlands · HQ
Founded 20246500+ followers
  • Biotechnology
Updated 7 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

1 founder

Lucas Czentner

Co-Founder/CEO

Product

Features

  • The startup provides cancer immunotherapy services utilizing RNA nanoparticles that instruct the immune system to identify and target cancer cells. This approach enhances the effectiveness of RNA medicines, improving patient immunization and recovery times.
This profile is AI-generated and may contain inaccuracies.